{
  "id": "shwachman-diamond-syndrome",
  "title": "Shwachman–Diamond syndrome",
  "lang": "en",
  "source_lang": "en",
  "summary": "Shwachman–Diamond syndrome is a rare inherited disorder characterized by pancreatic dysfunction, impaired blood-cell production, skeletal abnormalities, and increased risk of myeloid cancers.",
  "category": "health",
  "subcategory": "diseases",
  "type": "concept",
  "aliases": [
    "Shwachman–Bodian–Diamond syndrome",
    "Shwachman syndrome",
    "SDS"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/shwachman-diamond-syndrome/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/shwachman-diamond-syndrome/",
      "json": "https://aiwiki.page/zh/shwachman-diamond-syndrome.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Shwachman–Diamond syndrome (SDS) is a rare inherited disorder that primarily affects the exocrine pancreas, bone marrow, and skeleton. Its characteristic features include reduced production of pancreatic digestive enzymes, low blood-cell counts—especially neutropenia—and abnormalities of skeletal development or growth. The combination and severity of these features vary considerably, and not every affected person has all of them at diagnosis. SDS is an inherited bone-marrow-failure syndrome and confers an increased risk of myelodysplastic syndrome and acute myeloid leukemia."
    },
    {
      "heading": "Genetic basis and disease mechanism",
      "text": "Most molecularly confirmed cases result from disease-causing variants in both copies of the SBDS gene. This form follows autosomal recessive inheritance: an affected person generally inherits one altered copy from each parent, who usually has no symptoms. When both parents carry a disease-causing variant in the same recessive disease gene, each pregnancy has a 25% probability of producing an affected child.\n\nThe SBDS protein participates in the maturation of ribosomes, the cellular structures responsible for making proteins. Together with the protein EFL1, it helps release an assembly factor from the large ribosomal subunit, allowing that subunit to enter productive protein synthesis. Impaired ribosome maturation disrupts cellular function and activates stress responses. Blood-forming cells and pancreatic enzyme-producing cells are particularly vulnerable, although the reasons for the disorder’s tissue-specific effects are not fully understood.\n\nDisease-causing variants in EFL1 and DNAJC21, which also participate in ribosome-related processes, can produce overlapping SDS phenotypes. Variants in SRP54 cause an overlapping disorder that often features congenital neutropenia and sometimes pancreatic dysfunction; unlike classic SBDS-related SDS, this condition generally follows dominant inheritance. The terms “SDS” and “SDS-like disorder” are therefore used with some variation across clinical and genetic literature."
    },
    {
      "heading": "Clinical features",
      "text": "Pancreatic dysfunction and growth\n\nExocrine pancreatic insufficiency results from impaired development or loss of pancreatic acinar cells, which normally produce digestive enzymes. Fatty replacement of pancreatic tissue is common. Reduced enzyme secretion interferes with digestion and nutrient absorption, potentially causing bulky or greasy stools, diarrhea, poor weight gain, and deficiencies of fat-soluble vitamins.\n\nPancreatic symptoms often become apparent during infancy. Exocrine function can improve with age, and some affected people later no longer require enzyme replacement. Such improvement does not remove the underlying disorder or its blood-related risks.\n\nShort stature is common and may reflect both impaired nutrient absorption and intrinsic abnormalities of growth and skeletal development. Consequently, normalizing nutrition does not necessarily normalize height.\n\nBlood and immune abnormalities\n\nNeutropenia, a reduction in circulating neutrophils, is the most frequent blood abnormality. It may be persistent or intermittent, so a single normal blood count does not exclude SDS. Neutrophil function can also be impaired.\n\nOther abnormalities include anemia and reduced platelet counts. Some individuals develop progressive failure of multiple blood-cell lineages. These changes can contribute to recurrent infections, fatigue, or bleeding, although manifestations differ substantially among patients.\n\nSkeletal and other manifestations\n\nSkeletal findings include metaphyseal abnormalities, particularly near the growing ends of long bones, and changes affecting the ribs or chest wall. Low bone mineral density and osteoporosis may occur.\n\nAdditional manifestations can include elevated liver enzymes, especially in younger children, dental abnormalities, and developmental or learning difficulties. These findings are variable rather than universal. The disorder’s multisystem nature means that its clinical presentation may extend beyond the traditional combination of pancreatic insufficiency and neutropenia."
    },
    {
      "heading": "Bone-marrow failure and cancer predisposition",
      "text": "SDS is associated with an increased risk of progressive marrow failure, myelodysplastic syndrome, and acute myeloid leukemia. These complications can develop during childhood or adulthood.\n\nBlood-forming cells may acquire additional genetic changes over time, creating populations of related cells known as clones. Some acquired changes can partly compensate for the underlying ribosome defect, whereas others are associated with malignant progression. Thus, the presence of a clone or a chromosome abnormality does not, by itself, establish that cancer is present.\n\nInterpretation depends on the specific abnormality, changes in blood counts, marrow morphology, and molecular findings over time. Certain chromosome abnormalities observed in SDS, including an isochromosome of chromosome 7 or deletion of part of chromosome 20, do not invariably indicate impending leukemia."
    },
    {
      "heading": "Diagnosis",
      "text": "Diagnosis combines clinical findings, laboratory assessment, and molecular genetic testing. The characteristic association of pancreatic dysfunction with blood-cell abnormalities is an important clue, but either component may initially be subtle or absent.\n\nInvestigations used in assessment include:\n\n- A complete blood count with differential, often repeated because neutropenia can fluctuate.\n- Tests of pancreatic function, including fecal elastase and age-appropriate serum pancreatic markers.\n- Assessment of growth, nutrient absorption, and fat-soluble vitamin status.\n- Pancreatic imaging, which may demonstrate fatty replacement.\n- Bone-marrow examination, including biopsy, chromosome analysis, and molecular studies when indicated.\n- Genetic testing for SBDS and other genes associated with overlapping phenotypes.\n\nTesting SBDS can be technically challenging because a nearby pseudogene has a highly similar sequence. Laboratory methods must distinguish the functional gene from the pseudogene and detect relevant classes of variants.\n\nThe differential diagnosis includes cystic fibrosis, Pearson syndrome, isolated congenital neutropenia, and other inherited marrow-failure disorders such as Fanconi anemia. A negative result on a limited genetic test does not automatically exclude an SDS-spectrum disorder."
    },
    {
      "heading": "Clinical management",
      "text": "Management addresses the affected organ systems and the possibility of evolving marrow disease. It commonly involves hematology, gastroenterology, clinical genetics, nutrition, and other specialties.\n\nPancreatic enzyme replacement and correction of documented nutritional deficiencies are established components of care for pancreatic insufficiency. Growth, skeletal health, and developmental needs are assessed over time. Treatment of significant infections may involve antibiotics, and granulocyte colony-stimulating factor is used in selected patients with clinically significant neutropenia or recurrent serious infections.\n\nLongitudinal hematologic assessment commonly includes blood counts and periodic marrow evaluation. Its purpose is to identify worsening marrow function or evidence of myeloid malignancy; specific surveillance protocols vary among specialist centers.\n\nHematopoietic stem-cell transplantation can replace the abnormal blood-forming system and is used for severe marrow failure or myeloid malignancy. It does not correct pancreatic insufficiency, skeletal abnormalities, or all other manifestations of SDS. Transplantation carries substantial risks, and conditioning regimens account for the disorder’s associated organ vulnerabilities.\n\nGenetic counseling addresses inheritance, testing of relatives, and reproductive implications."
    },
    {
      "heading": "Epidemiology and history",
      "text": "SDS is rare, and its true prevalence is uncertain. Variable expression, improvement of pancreatic symptoms with age, and overlap with other disorders can contribute to underrecognition.\n\nThe syndrome was delineated in clinical reports in 1964 and is named for Harry Shwachman and Louis K. Diamond; the expanded name also recognizes Martin Bodian. Identification of SBDS in 2003 established the molecular basis of most classic cases and connected the disorder to defective ribosome maturation.\n\nThe clinical course ranges from relatively stable pancreatic and blood abnormalities to severe infections, marrow failure, or leukemia. Prognosis depends strongly on hematologic complications and differs substantially between individuals, including those with the same underlying genetic variants."
    }
  ],
  "links": [
    "pancreas",
    "bone-marrow",
    "neutropenia",
    "myelodysplastic-syndrome",
    "acute-myeloid-leukemia",
    "gene",
    "autosomal-recessive-inheritance",
    "ribosome",
    "exocrine-pancreatic-insufficiency",
    "enzyme",
    "digestion",
    "diarrhea",
    "anemia",
    "osteoporosis",
    "cancer",
    "diagnosis",
    "complete-blood-count",
    "biopsy",
    "differential-diagnosis",
    "cystic-fibrosis",
    "fanconi-anemia",
    "antibiotic",
    "hematopoietic-stem-cell-transplantation",
    "prevalence"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}